Aegean Marine Story...
Health Care: Drugs
Ista Pharmaceuticals Inc. (ISTA: NASDAQ)
$8.15 -0.02 | -0.24%
02/08/12 - 04:00 PM ET
240.54K / 379.50K
Vol / Avg. Vol:8.18 / 8.17
Open / Prev. Close:8.08 - 8.19
Today's Range:2.88 - 11.39
52 Wk Range:15.60%
Performance YTD:TheStreet Rating:
Portfolios with ISTA
- Portfolio NameUser Type
- UserMiriam Hoath
- Contributor13 Biotech Stocks Bought an...
- UserSmall Cap Bargains to follo...
- UserLong Term.EnvyV07
- Userjmluckey2000 Portfolio 1
- Userviolacasey portfolio 2
- Userviolacasey Portfolio 1
- UserSUPRATRADE 3007071748
- Usertterragjm Portfolio 1
- UserRolling stone no moss
Latest ISTA Headlines from TheStreet
- Valeant Pulls Ista Pharma Takeout Bid 01.30.12 | 08:01 am
- Stocks End Higher on Global Data 01.17.12 | 04:01 pm
- Stock Futures Climb with Chinese Growth Data 01.17.12 | 09:01 am
- Stocks to Watch: Carnival, Ista, Ameritrade (Update 1) 01.17.12 | 07:01 am
- 5 Stocks Under $10 Set to Soar 12.16.11 | 01:12 pm
- Ista Stock Gaps Down On Today's Open (ISTA) 07.29.11 | 09:07 am
- Ista Stock Falls On Unusually High Volume (ISTA) 05.13.11 | 01:05 pm
- 3 Magnificent Microcaps
03.24.11 | 10:03 am - Greenhouse CEO, Investing In Japan, Small Cap Stars 03.18.11 | 04:03 pm
- Stock Wrap: The Real Story, March 18 03.18.11 | 04:03 pm
Press Releases for ISTA
- Block & Leviton LLP Investigates ISTA Pharmaceuticals, Inc.'s Board Of Directors For Possible Breaches Of Fiduciary Duty - PR Newswire 12.16.11 | 05:12 pm
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of ISTA Pharmaceuticals, Inc. In Connection With A Merger Proposal By Valeant Pharmaceuticals International, Inc. - PR Newswire 12.16.11 | 12:12 pm
- Bernstein Liebhard LLP Announces Investigation Of Offer For ISTA Pharmaceuticals, Inc. - Business Wire 12.16.11 | 10:12 am
- ISTA Pharmaceuticals Achieves 2010 Revenue And Earnings Guidance; Provides 2011 Financial Guidance And Updates Key Plans - PR Newswire 01.05.11 | 04:01 pm
- ISTA Pharmaceuticals Initiates Phase 2 Clinical Study Of Bepotastine Besilate Nasal Spray For The Treatment Of Symptoms Associated With Seasonal Allergic Rhinitis - PR Newswire 12.14.10 | 07:12 am
- ISTA Pharmaceuticals Granted Three-Year Market Exclusivity For BROMDAY⢠- PR Newswire 11.17.10 | 07:11 am
- ISTA Pharmaceuticals Receives FDA Approval For BROMDAY⢠- PR Newswire 10.16.10 | 12:10 pm
- ISTA Pharmaceuticals Reports Positive Preliminary Results From Its Phase 1/2 Clinical Study Of Bepotastine Besilate Nasal Spray For The Treatment Of Symptoms Associated With Seasonal Allergic Rhinitis - PR Newswire 10.06.10 | 07:10 am
- ISTA Pharmaceuticals Highlights Clinical Data From REMURA⢠Phase 2 Study Presented At The 6th International Conference On The Tear Film & Ocular Surface - PR Newswire 09.27.10 | 07:09 am
- ISTA Pharmaceuticals Initiates Phase 3 Clinical Program For REMURA⢠In Dry Eye Disease - PR Newswire 09.16.10 | 07:09 am
Partner Headlines for ISTA
- Company News for January 18, 2012 - Corporate Summary - Zacks 01.18.12 | 10:01 am
- UPDATE: Auriga Downgrades ISTA Pharmaceuticals to Hold, $9 PT - Benzinga 01.18.12 | 09:01 am
- ISTA Pharma Sees 2012 EPS $0.28-$0.36 vs $0.39 Est; Revs $180M-$195M vs $195.67M Est - Benzinga 01.04.12 | 04:01 pm
- Benzinga's M&A Chatter for Friday December 16, 2011 - Benzinga 12.16.11 | 04:12 pm
- 20 Smart Money Stock Picks Trading Under $5 - Seeking Alpha 11.03.11 | 07:11 am
- Stocks Lower as China Data Weighs; Unemployment Claims Flat - NASDAQ 10.13.11 | 04:10 pm
- Mid-Day Update: Stocks Sitting Lower as JPMorgan Earnings, Chinese Data Weigh - NASDAQ 10.13.11 | 04:10 pm
- ISTA Pharmaceuticals Pushing on Daily Highs - Benzinga 07.12.11 | 01:07 pm
- Mylan Launches New Generics - Analyst Blog - Zacks 05.26.11 | 06:05 pm
- 31 Undervalued Small Caps - Seeking Alpha 04.11.11 | 09:04 am
